RSV appears to consistently downregulate inflammatory markers, such as C-reactive protein and tumour necrosis factor-α, in a number of disease states, including T2DM, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD) [162,163,164]. This evidence concerns the gene CRP and type 2 diabetes mellitus.